49 results
POS AM
SYRE
Spyre Therapeutics Inc.
26 Mar 24
Prospectus update (post-effective amendment)
6:30pm
MANAGEMENT
EXECUTIVE COMPENSATION
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
CERTAIN RELATIONSHIPS … and smaller reporting companies have reduced disclosure obligations regarding executive compensation.
The Offering
Shares Offered by the Selling
POS AM
SYRE
Spyre Therapeutics Inc.
14 Mar 24
Prospectus update (post-effective amendment)
4:12pm
DISCLOSURES ABOUT MARKET RISK
BUSINESS
MANAGEMENT
EXECUTIVE COMPENSATION
SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED … reduced disclosure obligations regarding executive compensation.
The Offering
Shares Offered by the Selling Securityholders
Up to (i) 8,864 shares
POS AM
0g4h7620wxstlws7vp5
5 Mar 24
Prospectus update (post-effective amendment)
5:15pm
PRER14A
9ix2k4mc83
6 Oct 23
Preliminary revised proxy
9:40pm
CORRESP
x0agc110p8 jhqydvk
6 Oct 23
Correspondence with SEC
12:00am
PRE 14A
ypi58p
7 Apr 23
Preliminary proxy
4:02pm